Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06363929 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring in Neonatal Hyperinsulinism
A clinical trial, sponsored by MemorialCare Health System.
- Terminated
- Registry status
- 1
- Enrollment target
NCT06363929: Clinical Trial study, sponsored by MemorialCare Health System.
NCT06363929 is a clinical trial that was terminated before completion, run by MemorialCare Health System. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06363929 was terminated before completion, sponsored by MemorialCare Health System.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The investigators are studying the accuracy of Dexcom G6 continuous glucose monitors placed on babies with hyperinsulinism in the Miller Children's Hospital Neonatal Intensive Care Unit. The participants will wear the device for 10 days on their lateral thigh. Whenever blood sugars are checked by glucometer, the investigators will also record the continuous glucose monitor sugar. Additionally, if the continuous glucose monitor alarms for a low sugar or an impending low sugar, the investigators will check the blood sugar by glucometer and, if verified to be low, treat the low blood sugar accordingly.
Primary Outcome
Mean absolute relative difference (MARD) between Dexcom G6 glucoses and point of care blood or plasma glucoses.
Interventions
- DEVICE Dexcom G6 continuous glucose monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-09-22 |
Why NCT06363929 stopped before completion
NCT06363929 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dexcom G6 continuous glucose monitor is the first listed.
NCT06363929 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06363929 about?
NCT06363929 is a clinical study titled "Continuous Glucose Monitoring in Neonatal Hyperinsulinism". The investigators are studying the accuracy of Dexcom G6 continuous glucose monitors placed on babies with hyperinsulinism in the Miller Children's Hospital Neonatal Intensive Care Unit. The participants will wear the device for 10 days on their lateral thigh. Whenever blood sugars are checked by gl...
What is the current status of trial NCT06363929?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2023-06-01. Estimated completion is 2025-09-22.
What interventions are being tested in trial NCT06363929?
The interventions under investigation include: Dexcom G6 continuous glucose monitor (DEVICE).
Who is sponsoring clinical trial NCT06363929?
This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI